Mammary Cell News Volume 14.03 | Jan 27 2022

    0
    73







    2022-01-27 | MCN 14.03


    Mammary Cell News by STEMCELL Technologies
    Vol. 14.03 – 27 January, 2022
    TOP STORY

    Tumor ENPP1(CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

    Researchers unveiled the ectonucleotide pyrophosphatase /phosphodiesterase 1 (ENPP1)/Haptoglobin axis as an unanticipated mechanism exploited by tumor cells linking inflammation to immune remodeling favoring local relapse.
    [Cancer Discovery]

    AbstractFull Article
    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Targeted Nanoparticle for Co-Delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

    A single therapeutic was developed based on trastuzumab-conjugated nanoparticles for co-delivering docetaxel and siRNA against human epidermal growth factor receptor type 2 (HER2+).
    [Small]

    Abstract

    IKBKE Phosphorylates and Stabilizes Snail to Promote Breast Cancer Invasion and Metastasis

    Investigators revealed a novel oncogenic function of IKBKE in promoting breast cancer metastasis by governing Snail abundance, and highlighted the potential of targeting IKBKE for metastatic breast cancer therapies.
    [Cell Death & Differentiation]

    Abstract

    SELENOF Is a New Tumor Suppressor in Breast Cancer

    Restoring SELENOF could attenuate a number of aggressive cancer phenotypes in breast cancer cells, including clonogenic survival, and enhanced the response to drugs or radiation used in breast cancer therapy.
    [Oncogene]

    Abstract

    RICH1 Inhibits Breast Cancer Stem Cell Traits through Activating Kinases Cascade of Hippo Signaling by Competing with Merlin for Binding to Amot-p80

    Scientists found that the low expression of RICH1 in breast cancer was associated with poor prognosis. Depletion of RICH1 promoted the stemness and disrupted the normal epithelial architecture of MCF10A cells.
    [Cell Death & Disease]

    Full Article

    Prognostic Implications of N6-Methyladenosine RNA Regulators in Breast Cancer

    Investigators used a series of bioinformatics methods and experiments to conduct exploratory research on the possible role of m6A regulators in breast cancer (BC) and revealed that YTHDF1 could serve as a new molecular marker for BC immunotherapy.
    [Scientific Reports]

    Full Article

    Flexible Etherified and Esterified Triphenylethylene Derivatives and Their Evaluation on ER Positive and Triple Negative Breast Cancer Cell Lines

    Tamoxifen (TAM) is a selective estrogen receptor modulator with potential clinical benefits for all stages of breast cancer. The authors reported novel TAM analogues that could avoid metabolism via CYP2D6.
    [Chemmedchem]

    Abstract

    Preparation of Modified Chitosan-Based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells

    Investigators developed a novel pH-responsive modified chitosan-based nanoparticles system for active loading of doxorubicin and triggered intracellular release. The cytotoxic effects of these nanoparticles were performed against the MCF-7 BrCA cell line under different pHs.
    [Current Cancer Drug Targets]

    Abstract

    Alpha-Mangostin Activates MOAP-1 Tumor Suppressor and Mitochondrial Signaling in MCF-7 Human Breast Cancer Cells

    Scientists investigated the cellular activities of α-mangostin, human cancer cells, MCF-7, and MCF-7-CR cells by treating them with α-mangostin to measure the cellular responses, including cytotoxicity, protein-protein interaction, and protein expression.
    [Evidence-Based Complementary and Alternative Medicine]

    Full Article

    Effects of Matcha Tea Extract on Cell Viability and Peroxisome Proliferator-Activated Receptor γ Expression on T47D Breast Cancer Cells

    Researchers investigated the nuclear peroxisome proliferator-activated receptor gamma-dependent proliferation behavior of breast cancer cells after stimulation with matcha green tea extract.
    [Archives of Gynecology and Obstetrics]

    Full Article
    Guide to everything you need to know about cell separation.
    REVIEWS

    Role of Nischarin in the Pathology of Diseases: A Special Emphasis on Breast Cancer

    The authors report the prognostic value, clinical relevance, and biological significance of the Nischarin gene in breast cancer patients using the Molecular Taxonomy of Breast Cancer International Consortium and The Cancer Genome Atlas datasets.
    [Oncogene]

    Abstract

    Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies

    Scientists specifically review the data for the management of HER2+ parenchymal brain metastases and provide an overview of ongoing clinical trials which include patients with HER2+ brain metastases.
    [CNS Drugs]

    Abstract
    INDUSTRY AND POLICY NEWS

    ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications

    ORIC Pharmaceuticals, Inc. announced clearance of its Clinical Trial Application by the regulatory authorities of the Republic of Korea for ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations.
    [ORIC Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    The Australasian Society for Stem Cell Research (ASSCR) Annual Meeting

    March 9 – 11, 2022
    Melbourne, Victoria, Australia

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Cancer Biology

    University of Bristol – Bristol, United Kingdom

    Postdoctoral Fellows – Cancer Research

    The Wistar Institute – Philadelphia, Pennsylvania, United States

    Pathologist – Surgical Cases

    Brigham and Women’s Hospital – Boston, Massachusetts, United States

    Postdoctoral Student – Systems Biology

    Charity-University Medicine Berlin – Berlin, Germany

    Postdoctoral Fellowship – Breast Cancer Immunology

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter